Introduction
Polymorphonuclear leukocytes (PMN), abundant cells of an early phase of inflammation, have ability to release a wide range of cytokines and their soluble receptors, which influence the host's non-specific and specific immune response.
1 Interleukin (IL)-6 and its soluble receptors, soluble interleukin-6 receptor a (sIL-6R a ) and sgp130, among the known soluble modulators secreted by PMN, appear to be important for a host's response. 2, 3 IL-6 plays a key role in inducing and maintaining inflammatory responses. 3 On the contrary, IL-6 acts also as an anti-inflammatory mediator through downregulation of pro-inflammatory cytokines, such as IL-1 b and TNF-a , and simultaneous induction of the IL-1 receptor antagonist and the soluble p55 TNF-a receptor expression. 4 The receptor complex mediating the biological activities of IL-6 consists of two membrane-bound proteins, an 80-kDa ligand binding subunit (IL-6R) and a gp130-kDa signal-transducing subunit. 5 Both the IL-6R and gp130 receptors exist in a soluble form.
The soluble IL-6R a , which lacks the transmembrane and cytoplasmic parts, is generated through proteolytic shedding of a membrane-anchored protein (PC-sIL-6R isoform) or released as a product of alternative mRNA splicing (DS-sIL-6R isoform). 2, 6 In contrast to the most soluble cytokine receptors, sIL-6R exerts agonistic activity when complexed with its ligand. It is known that sIL-6R might act as a regulator in a wide variety of both normal and abnormal biologic reactions. The complex sIL-6R/IL-6 is capable of activating cells through interaction with membrane-bound gp130. By means of this mechanism, sIL-6R might render IL-6-responsive cells, which by themselves cannot bind IL-6. Furthermore, sIL-6R is a carrier protein for its IL-6 ligand, prolonging the plasma half-life of IL-6. 5, 6 It has recently been shown that soluble IL-6 receptor alone could be an effective stimulator of the cell function. 7, 8 Modur et al. demonstrated that PMN exposed to fMPL shed IL-6R in sufficient quantities to activate the inflammatory response of endothelial cells. 7 The key question of the present study is whether the sIL-6R a released by PMN can also influence the cytokine secretion by peripheral blood mononuclear cells (PBMC), which together with neutrophils develop the inflammatory and immune response of a host. Since IL-6 and TNF-a co-stimulate each other's release and IL-6 is one of the most efficient modulators of TNF-a production, we examined the effect of sIL-6R and sIL-6R with IL-6 secreted by PMN on TNF-a expression and its production by PBMC. Our studies of the biological function of sIL-6R and IL-6 secreted by PMN may provide new data on the early phase of inflammation and immune response mediated by these cells.
Material and methods
Cells were isolated from heparinized (10 U/ml) whole blood of 12 healthy persons by Gradisol G gradient (1.115 g/ml). This method enables the simultaneous separation of two highly purified leukocyte fractions: PBMC containing 95% lymphocytes, and polymorphonuclear cells cont. 94% PMN. The purity of isolated PMN was determined by May-Grunewald-Giemsa staining. The cells were washed three times with RPMI 1640 medium (Gibco, Paisley, Scotland) and suspended in the culture medium to provide 5 ´10 6 cells/cm 3 . The culture medium consisted of RPMI 1640 medium supplemented with 10% autologous serum (Pro Animal, Wroclaw, Poland), 100 U/ml of penicillin and 50 ng/ml of streptomycin.
The PMN were cultured in flat-bottomed, 96-well plates (Falcon, Franklin Lakes, USA) for 1 h at 37°C in a humidified incubator with 5% CO 2 (Nuaire™, Minnesota, USA). After 1 h incubation, the culture supernatant of PMN was removed and added to PBMC (5 ´10 6 cells/cm 3 ). The viability of PMN was > 92% as determined by trypan blue exclusion. The PBMC were cultured for 1 h at 37°C in the same conditions. PBMC with the culture supernatants of PMN and monoclonal antibodies anti-sIL-6R (20 ng/ml) and anti-IL-6 (20 ng/ml) were the negative control, whereas PBMC with recombinant human (rh) sIL-6R (Endogen, Woburn, USA) and rhIL-6 (R&D, Minneapolis, USA) were the positive control.
In the culture supernatants and lysates of PMN, we examined the concentrations of sIL-6R by the human sIL-6R enzyme-linked immunosorbent assay (ELISA) (Biosource, Nivelles, Belgium).
TNF-a was measured at both protein and mRNA levels. Protein levels were determined by the Human TNF-a ELISA (Biosource). To examine TNF-a mRNA expression, we isolated mRNA from PBMC after culture, using TRIZOL Reagent (Gibco), according to the manufacturer's instruction. The quantity of mRNA TNF-a was determined by the Quantikine mRNA assay (Base Kit, Quantikine mRNA Probes and Calibrator Kit -Human TNF-a ; R&D Systems).
The concentration of RNA samples was determined at A 260 and A 280 using absorbance values in the linear range of the spectrophotometer. The A 260 /A 280 ratio for RNA samples was 1.8-1.9.
Results

TNF-a mRNA in PBMC
In the PBMC, after the culture with PMN supernatants, we found a lower expression of TNF-a mRNA than in PBMC cultured without supernatants from PMN ( Fig. 1) . Anti-sIL-6R alone and anti-sIL-6R with anti-IL-6 monoclonal antibodies were used to confirm whether the actions of PMN supernatant were generated by these proteins. In the presence of anti-sIL-6R antibodies alone, the expression of TNF-a mRNA in PBMC cultured with PMN supernatants was not changed. In contrast, in the presence of anti-sIL-6R with anti-IL-6 monoclonal antibody, the expression of TNF-a mRNA in PBMC was higher than in the PBMC cultured without PMN supernatants (Fig. 1A) .
We examined TNF-a expression in PBMC in the presence of rhsIL-6R alone and in the presence of rhsIL-6R with rhIL-6 to confirm the observations just mentioned. A similar expression of TNF-a mRNA was found in PBMC cultured without PMN supernatant and PBMC cultured with rhsIL-6R alone. In the presence of rhsIL-6R and rhIL-6, the expression of TNF-a mRNA in PBMC was lower than in PBMC cultured without PMN supernatant.
TNF-a concentrations in the culture supernatants of PBMC TNF-a concentrations in the culture supernatants of PBMC cultured in the presence of PMN supernatants were lower than those in the supernatants of PBMC cultured without PMN supernatants (Fig. 1B) .
The presence of anti-sIL-6R antibody in the culture of PBMC with PMN supernatants induced the same level of TNF-a secretion as in the culture of PBMC alone. In the presence of anti-sIL-6R with anti-IL-6, the concentration of TNF-a in the PBMC supernatant was higher than in the culture supernatant of PBMC cultured with PMN supernatant. We stimulated PBMC with rhsIL-6R alone and rhsIL-6R with rhIL-6 to confirm the effect of these mediators secreted by PMN on TNF-a production by PBMC. The concentrations of TNF-a in the culture supernatants of PBMC with rhsIL-6R were no changed. The secretion of TNFa by PBMC in the presence of rhsIL-6R with rhIL-6 was lower than secretion by PBMC without PMN supernatant.
Discussion
Soluble forms of receptors are known to be more general phenomena and may play a wider physiological role in the regulation of the immune system than recognized previously. The results obtained indicate that sIL-6R with IL-6 secreted by PMN belong to the factors responsible for the TNF-a expression and its production by autologous PBMC. Joyce et al. showed that induction of PMN can lead to synthesis of other cytokines, such as IL-1, granulocyte-macrophage colony-stimulating factor or TNF-a , which have also been demonstrated to induce the TNF-a production by mononuclear cells. 9 There are different data referring to the biological activity of sIL-6R alone or complexed with IL-6. Modur et al. found that sIL-6R did not require the addition of exogenous IL-6 to the surface expression of E-selectin, intracellular adhesion molecule-1, vascular cell adhesion molecule-1 and the synthesis of IL-8 and IL-6 by these cells. 7 However, our observations suggest that sIL-6R alone does not exert an effect on TNF-a expression in PBMC.
The observations referring to the sIL-6R and IL-6 function seem to be similar to the other's results and appear to confirm the inhibitory inter-relations between IL-6 and TNF-a . 8, 10 Schindler et al. reported that IL-6 suppressed TNF-a production by human blood mononuclear cells. 11 Oh et al. demonstrated that the IL-6/sIL-6R complex inhibited TNF-a -induced vascular cell adhesion molecule-1 expression, whereas it did not affect intracellular cell adhesion molecule-1 expression. 8 There are available data indicating that IL-6 and TNF-a can be modulated by their soluble receptors and vice versa. 4, 6 For example, IL-6 has been found as a stimulator of soluble TNFRp55 receptor secretion. This receptor retains the capacity of binding TNF and may directly neutralize or modulate TNF activity as well as possibly indirectly influencing the IL-6 function. 10 Igaz et al. described the inhibiting action of the sIL-6R/IL-6 on the TNF-a secretion but not on the mRNA TNF-a expression by Jurkat cells. They also found that sIL-6R alone did not influence the TNF-a production by these cells. 12 However, little is known about the biological role of a second IL-6 soluble receptor, sgp130, also secreted by PMN and PBMC. Soluble gp130 has been shown to bind the bio-active IL-6/IL-6R complex and to inhibit its function. 6, 13 In our earlier studies, we demonstrated the ability of PMN to release sgp130 at a 10-fold higher level than sIL-6R. 14 The presence of the relatively large amount of sgp130 in the culture medium may affect differently the biological function of sIL-6R. The presence of sgp130, inhibiting IL-6 activity in the culture supernatants of PMN in a paracrine fashion as well as of PBMC in an autocrine fashion, may be directly responsible for the modulation of TNF-a expression and its production by PBMC. Moreover, the recent data of Mueller-Neuwen et al. indicate that sIL-6R enhances the antagonistic effect of sgp130 and that this effect is more pronounced at higher concentrations of IL-6, sIL-6R and sgp130. 15 Furthermore, the role of both isoforms of sIL-6R produced by PMN in the immune response should be considered when determining the properties of sIL-6R. It is known that the PC-sIL-6R and DS-sIL-6R isoforms may independently contribute to the action of this receptor. 6 In the present examinations, we derived the sIL-6R from the conditioned medium of PMN within 60 min. The sIL-6R obtained in these examinations may be the PC-sIL-6R isoform that can be detected within the first 30-120 min of stimulation. 6 In conclusion, the results obtained revealed that sIL-6R with IL-6 secreted by human PMN may play a regulatory function in the immune response by modulating the TNF-a expression and its production by PBMC. Decreased TNF-a expression and its production by sIL-6R and IL-6-stimulated PBMC may have a significant influence on an early phase of the inflammation, mediated by TNF-a . 8, 10 The data presented can form a base for clinical research in the course of infections, in which IL-6 and TNF-a , as well as their soluble receptors, play a key role.
